Taking the Oncofocus® Test: Karan’s Testimony
Karan Jensen was diagnosed in 2017, aged 48 with cervical cancer. Karan ordered the Oncofocus® Test to identify additional treatment options and shares her story here in the following Q&A. How did your diagnosis come about? I had been having regular smear...
‘Revolutionary’ new class of cancer drugs approved
A “revolutionary” new class of cancer drug that can treat a wide range of tumours has been approved for use in Europe for the first time. Tumour-agnostic drugs do not care where the cancer is growing in the body as long as it has a specific genetic abnormality...
The most precise treatments with genetic tests
Molecular genetic testing identified the most precise treatments Genetic testing not only provides information regarding the chance of developing a particular disease but is also crucial in identifying the most effective anti-cancer therapy for each individual...
Sherrie Hewson’s brother diagnosed with an “incurable” brain tumour now enlisted the help of a special medical company called Oncologica®
Sherrie Hewson was due on stage when her phone rang with shattering news. The Coronation Street favourite’s beloved elder brother Brett had been diagnosed with an incurable brain tumour. He was given 18 months to live. Sherrie, 68, burst into floods of tears in...
What does personalised medicine mean for you?
Medicine has always been personal to some extent – a doctor looks for the best way to help the patient sitting in front of them. But with advances in technology, it is becoming possible to use the most unique of characteristics – our genomes – to tailor treatments...
Mutations Matter: Cholangiocarcinoma Tumor Profiling Awareness
At least half of patients with cholangiocarcinoma have mutations in their tumors that may be treatable with targeted drugs or immunotherapies that are either experimental or approved for other cancer types. These are available through clinical trials. Yet when...
Genomic Profiling in Sarcoma Shows Potential in Guiding Clinical Management
A new single-center report has found that the results of next-generation sequencing (NGS)–based molecular profiling for non–GI stromal tumor (non-GIST) sarcomas provided information used to effectively guide clinical management. A team of authors led by Spandana...
Immunotherapy: new hope in the battle against cancer
Immunotherapy is a burgeoning sector that heralds a breakthrough against the world’s second-most deadly disease. Dr Mike Tubbs explains how investors can benefit too. Cancer is the world’s second-biggest killer. The disease is responsible for around one in six...
Oncofocus® Cancer Test is now covered by all leading health insurers
Following signature of an agreement between Oncologica® UK Ltd and another UK private medical insurer, all the leading UK health insurers’ customers now have access to the Oncofocus® Cancer Test. The Oncofocus® Cancer Test is the world’s most comprehensive genomic...
Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs
The impact of precision oncology on guiding treatment decisions of late-stage cancer patients was previously studied in a retrospective analysis. However, the overall survival and costs were not previously evaluated. We report the overall survival and healthcare...